The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1869-1878

  Grace, Michael J ^a   Xie, Lei ^a   Musco, Mary L ^a   Cui, Shijun ^a   Gurnani, Maya ^a   DiGiacomo, Ruth ^a   Chang, Alice ^a   Indelicato, Stephen ^a   Syed, Jameel ^a   Johnson, Robert ^a   Nielsen, Loretta L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PROTEIN P53;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; CYTOMETRY; GENE TARGETING; GENE THERAPY; HUMAN; LIVER BIOPSY; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE; XENOGRAFT;

EID: 0032778529     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65506-X     Document Type: Article

References (23)

1. Harris C, Hollstein M: Clinical implications of the p53 tumor-suppresser gene. N Engl J Med 1993, 329:1318-1327
2. Lane D, Lu X, Hupp T, Hall P: The role of p53 in the apoptotic response. Phil Trans R Soc London Ser. B, 1994, 345:277-280
3. Nielsen L, Maneval D: p53 tumor suppressor gene therapy for cancer. Cancer Gene Ther 1998, 5:52-63
4. Berkner K: Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 1998, 6:616-624
5. Schuler M, Rochlitz C, Horowitz J, Schlegel J, Perruchoud A, Kommoss F, Bollinger C, Kauczor HU, Dalquen P, Fritz MA, Swanson S, Herrmann R, Huber C: A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Human Gene Ther 1998, 9:2075-2082
6. Nielsen L, Pegram M, Karlan B, Elkas J, Horowitz J: Opportunities for p53 tumor suppressor gene therapy in ovarian and other peritoneal cancers. Adenoviruses: Basic Biology to Gene Therapy. Edited by P Seth. Austin, TX, R.G. Landes, 1999, pp 295-303
7. Martin-Reay D, Kamentsky L, Weinberg D, Hollister K, Cibas E: Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors: Comparison with flow cytometry and image analysis. Am J Clin Pathol 1994, 102:432-438
8. Kamentsky L, Burger D, Gershman R, Kamentsky L, Luther E: Slide-based laser scanning cytometry. Acta Cytol 1997, 41:123-143
9. Sasaki K, Kurose A, Miura Y, Sato T, Ikeda E: DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry. Cytometry 1996, 23:106-109
10. Kamada T, Sasaki K, Tsuji T, Todoroki T, Takahashi M, Kurose A: Sample preparation from paraffin-embedoed tissue specimens for laser scanning cytometric DNA analysis. Cytometry 1997, 2:290-294
11. Gorczyca W, Darzynkiewicz Z Melamed M: Laser scanning cytometry in pathology of solid tumors: A review. Acta Cytol 1997, 41:98-108
12. Clatch R, Walloch J, Zutter M, Kamentsky L: Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am J Clin Pathol 1996, 105:744-755
13. Clatch R, Walloch J: Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry. Acta Cytol 1997, 41:109-122
14. Gorczyca W, Sarode V, Melamed M, Darzynkiewicz Z: Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Mod Pathol 1997, 10:457-462
15. Musco M, Cui S, Small D, Nodelman M, Sugarman B, Grace M: Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry 1998, 33:290-296
16. Deptala A, Bedner E, Gorczyca W, Darzynkiewicz Z: Activation of nuclear factor kappa B (NF-κB) assayed by laser scanning cytometry (LSC). Cytometry 1998, 33:376-382
17. Nielsen L, Lipari P, Dell J, Gurnani M, Hajian G: Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Clin Cancer Res 1998, 4:835-846
18. Wills K, Maneval D, Menzel P, Harris M, Sutjipto S, Vaillancourt M, Huang W, Johnson D, Anderson S, Wen S, Bookstein R, Shepard H, Gregory R: Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Human Gene Ther 1994, 5:1079-1088
19. Huyghe B, Liu X, Sutjipto S, Sugarman B, Horn M, Shepard H, Scandella C, Shabram P: Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Human Gene Ther 1995, 6:1403-1416
20. Shabram P, Giroux D, Gouldreau A, Gregory R, Horn M, Huyghe B, Liu X, Nunnally M, Sugarman B, Sutjipto S: Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Human Gene Ther 1997, 8:453-465
21. Maizel J, White D, Scharff M: The polypeptides of adenovirus 1: evidence for multiple protein components in the virion and a comparison of types 2, 7a, and 12. Virology 1968, 36:115-125
22. Luther E, Kamentsky L: Resolution of mitotic cells using laser scanning microscopy. Cytometry 1996, 23:272-278
23. Nielsen L, Gurnani M, Syed J, Dell J, Hartman B, Cartwright M, Johnson R: Recombinant El-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models. Human Gene Ther 1998, 9:681-694